539997
KWALITY
Start SIP
Invest Now
Start SIP in KWALITY
Performance
- Low
- ₹1,321
- High
- ₹1,428
- 52 Week Low
- ₹596
- 52 Week High
- ₹1,428
- Open Price₹1,388
- Previous Close₹1,362
- Volume113,752
- 50 DMA₹1,080.84
- 100 DMA₹1,033.67
- 200 DMA₹978.78
Investment Returns
- Over 1 Month + 27.93%
- Over 3 Month + 59.02%
- Over 6 Month + 31.8%
- Over 1 Year + 80.11%
Smart Investing Starts Here Start SIP with Kwality Pharmaceuticals for Steady Growth!
Kwality Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 26
- PEG Ratio
- 0.3
- Market Cap Cr
- 1,468
- P/B Ratio
- 5.1
- Average True Range
- 71.78
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 24.95
- RSI
- 73.36
- MFI
- 79.96
Kwality Pharmaceuticals Financials
Kwality Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,415.00
+
53
(3.89%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,139.23
- 50 Day
- ₹1,080.84
- 100 Day
- ₹1,033.67
- 200 Day
- ₹978.78
Resistance and Support
1296.33
- R3 1,669.67
- R2 1,523.33
- R1 1,442.67
- S1 1,215.67
- S2 1,069.33
- S3 988.67
Kwality Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-12 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-11 | Quarterly Results | |
| 2025-05-19 | Audited Results | |
| 2025-01-31 | Quarterly Results |
Kwality Pharmaceuticals F&O
About Kwality Pharmaceuticals
- NSE Symbol
- KWALITY
- BSE Symbol
- 539997
- Managing Director
- Mr. Ramesh Arora
- ISIN
- INE552U01010
Similar Stocks to Kwality Pharmaceuticals
Kwality Pharmaceuticals FAQs
Kwality Pharmaceuticals share price is ₹1,415 As on 13 February, 2026 | 12:15
The Market Cap of Kwality Pharmaceuticals is ₹1468.2 Cr As on 13 February, 2026 | 12:15
The P/E ratio of Kwality Pharmaceuticals is 26 As on 13 February, 2026 | 12:15
The PB ratio of Kwality Pharmaceuticals is 5.1 As on 13 February, 2026 | 12:15
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.